For example, it must have the same active ingredient, same strength(s), same dosage form (i.e., oral tablet or injection), and the same usesalthough inactive ingredients may vary
The Hidden Risk: Sarcopenic Obesity One of the growing concerns following GLP-1 discontinuation is sarcopenic obesity
For anyone who passed on GLP-1 medications because of the injection requirement, the pill format removes that obstacle
24 GLP-1, used for treating diabetes, is quickly broken down in the body, requiring high doses that can cause side effects like nausea
2018;1864(9 Pt B):2814-2821
Myocardial remodelling characterized by fibrosis and hypertrophy, impaired microcirculation, abnormal protein function caused by advanced glycation end products, changes in myocardial metabolism and abnormal mitochondrial function have been noted as associated factors of diabetic cardiomyopathy [14]